Press Releases

STOCKHOLM, Jan. 30, 2020 /PRNewswire/ -- IRRAS will host a conference call and an online presentation of its Q4 2019 interim report (which will have been published earlier on the 14th at 08.00 a.m. CET). The presentation will be held in English.The dial-in numbers for the conference call are:

LONDON, Jan. 30, 2020 /PRNewswire/ -- Erba Mannheim strengthens its portfolio of powerful and affordable solutions with a burst of new launches and a preview of their next generation NEXUS total lab automation system.NEXUS total lab automation will offer p

GOTHENBURG, Sweden, Jan. 30, 2020 /PRNewswire/ -- Isofol Medical AB (publ) (Nasdaq First North Premier: ISOFOL), today announced that the method  for gene expression analysis has been validated by a commercial laboratory, a request from regulatory authorities for use in clinical practice.  Academic data from approximately 450 patients, all

STOCKHOLM, Jan. 30, 2020 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) reports that the MIV-818 patent portfolio has been reinforced by the issue of notices of allowance from the European Patent Office and the Japanese Patent Office for the MIV-818 composition-of-matter and liver cancer treatment claims.Corresponding notices of allowance or paten

GOTHENBURG, Sweden, Jan. 30, 2020 /PRNewswire/ -- Isofol Medical AB (publ) (Nasdaq First North Premier: ISOFOL), today announces that the recruitment and treatment of patients in the company's Phase 1/2a study with arfolitixorin has been completed. Totally 101 patients have been treated at 10 hospitals in the Nordic countries and Europe

GOTHENBURG, Sweden, Jan. 30, 2020 /PRNewswire/ -- "Our organic sales growth continued in the fourth quarter and it was particularly good to see the strong performance of our three largest markets - the US, China and Germany," says Mattias Perjos, President & CEO at Getinge. "We improved the margins

GOTHENBURG, Sweden, Jan. 30, 2020 /PRNewswire/ -- Isofol Medical AB (publ) (Nasdaq First North Premier: ISOFOL), today announced that over 200 patients of the planned 440 has been randomized in the global Phase 3 AGENT Study. The study has over 80 clinical sites in the U.S., Canada, Europe,

RENNAZ, Switzerland, Jan. 30, 2020 /PRNewswire/ --  Elekta (EKTA-B.ST) today announced that Hôpital Riviera-Chablais in Rennaz has treated the first patient in Switzerland using Elekta Unity MR-Linac, a magnetic resonance radiation therapy (MR/RT) system that enables personalized precision radiation therapy through real-time vi

WATERTOWN, Mass., Jan. 30, 2020 /PRNewswire/ -- Arranta Bio ("Arranta"), the leading microbiome contract development and manufacturing organization (CDMO), announced today the strengthening of its senior leadership team with the addition of David Stevens as Chief Operations Officer and Jason Rahal as Seni

CAMBRIDGE, England and MILPITAS, California, Jan. 30, 2020 /PRNewswire/ -- Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce the asset purchase of the gene editing platform and oncology product portfolio of Applied StemCell, Inc. (ASC) for life science research and diagnostic markets. ASC